A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and Ozempic, the company announced Thursday. The once-daily pill, called orforglipron, helped patients with Type 2 diabetes lower their drug sugar levels and lose weight during late-stage trials, the drugmaker said. The trial results are being...
Another state confirms measles case with infected child its first of year
- 04/19/2025, 6:44 PM
- foxnews.com
- 0
No comments